TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 8 | 29 | 13 | -18 | -30 | -78 | -13 |
| P | %wins | 100 | 100 | 100 | 0 | 0 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/27/19 08:33 | 11/25/19 | ONTX | Onconova Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Viren | PA | D | P.d | 50 | 0.2000 | 0 | 250 | 999% | 251 | D | |||||||||||||||
8/1/13 16:13 | 7/30/13 | ONTX | Onconova Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehta Viren | PA | D | P.d | 250 | 15.00 | 2 | 17 | 13 | 145 | M | 9 | 8 | 29 | 13 | -18 | -30 | -78 | ||||||||
10/24/05 19:15 | 10/21/05 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mehta Viren | NY | D | M.d | 528 | 7.85 | 0 | 67 | 639 | 78 | D | |||||||||||||||
9/17/04 17:09 | 9/15/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mehta Viren | NY | D | S | -1,867 | 62.24 | 0 | -30 | -83 | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |